Boehringer Ingelheim nabs new US president and CEO; AstraZeneca vet hops aboard Novavax as CMO
Coronavirus pharma news roundup – 19/06/20
When it comes to sustainable finance in the COVID era, let the private sector lead the way
Near-term pullback, long-term uptrend
Needham: 3 Conviction Buy Stocks to Snap up Now
2 “Strong Buy” Small-Cap Stocks That Could See Outsized Gains
US left with huge hydroxychloroquine stockpile after COVID-19 trial failures
9 in 10 Americans concerned pharma will use COVID-19 pandemic to raise drug prices
Gilead will test remdesivir in children with COVID-19
3 Pharmaceutical Stocks With Major Catalysts Approaching
3 “Strong Buy” Healthcare Stocks That Should Remain Healthy
100 days of coronavirus has sent shock waves through the food system
How investing in green infrastructure can jump-start the post-coronavirus economy
Dexamethasone: what is the breakthrough treatment for COVID-19?
3 "Strong Buy" Pharmaceutical Stocks With Major Catalysts Approaching
Kamada’s Covid-19 Therapy Approved For Compassionate Use In Israel
Cellular nanosponges could soak up SARS-CoV-2
How COVID-19 affects pediatric patients
UK stops recruitment to hydroxychloroquine COVID-19 trials
How doctors' fears of getting COVID-19 can mean losing the healing power of touch: One physician's story
All of Us Research Program launches COVID-19 research initiatives
EU Launches Two Antitrust Investigations Against Apple
How Much Has the World Changed? (Not much)
Futures Spike After Study Reveals Steroid Effective Against Advanced COVID-19
FDA warns against combination of malaria drug and Gilead’s remdesivir
The Hill: “Surging coronavirus cases raise fears of new lockdowns”
Is Now Still a Good Time to Buy Gilead Sciences (GILD) Stock? Oppenheimer Says 'Yes'
It's Time to End the Preference and Tax Capital Gains as Ordinary Income
Keeping up with the Genomes
Six Precision Medicine Companies Making Their Mark in 2020